Aging Increased Amyloid Peptide and Caused Amyloid Plaques in Brain of Old APP/V717I Transgenic Mice by a Different Mechanism than Mutant Presenilin1
- 1 September 2000
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 20 (17) , 6452-6458
- https://doi.org/10.1523/jneurosci.20-17-06452.2000
Abstract
Aging of transgenic mice that overexpress the London mutant of amyloid precursor protein (APP/V717I) (Moechars et al., 1999a) was now demonstrated not to affect the normalized levels of α- or β-cleaved secreted APP nor of the β-C-terminal stubs. This indicated that aging did not markedly disturb either α- or β-secretase cleavage of APP and failed to explain the origin of the massive amounts of amyloid peptides Aβ40 and Aβ42, soluble and precipitated as amyloid plaques in the brain of old APP/V717I transgenic mice. We tested the hypothesis that aging acted on presenilin1 (PS1) to affect γ-secretase-mediated production of amyloid peptides by comparing aged APP/V717I transgenic mice to double transgenic mice coexpressing human PS1 and APP/V717I. In double transgenic mice with mutant (A246E) but not wild-type human PS1, brain amyloid peptide levels increased and resulted in amyloid plaques when the mice were only 6–9 months old, much earlier than in APP/V717I transgenic mice (12–15 months old). Mutant PS1 increased mainly brain Aβ42 levels, whereas in aged APP/V717I transgenic mice, both Aβ42 and Aβ40 increased. This resulted in a dramatic difference in the Aβ42/Aβ40 ratio of precipitated or plaque-associated amyloid peptides, i.e., 3.11 ± 0.22 in double APP/V717I × PS1/A246E transgenic mice compared with 0.43 ± 0.07 in aged APP/V717I transgenic mice, and demonstrated a clear difference between the effect of aging and the effect of the insertion of a mutant PS1 transgene. In conclusion, we demonstrate that aging did not favor amyloidogenic over nonamyloidogenic processing of APP, nor did it exert a mutant PS1-like effect on γ-secretase. Therefore, the data are interpreted to suggest that parenchymal and vascular accumulation of amyloid in aging brain resulted from failure to clear the amyloid peptides rather than from increased production.Keywords
This publication has 29 references indexed in Scilit:
- Does Alzheimer disease tilt the scales of amyloid degradation versus accumulation?Nature Medicine, 2000
- Additive Effects of PS1 and APP Mutations on Secretion of the 42-Residue Amyloid β-ProteinNeurobiology of Disease, 1998
- Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor proteinNature, 1998
- Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor ProteinsNeuron, 1997
- Amyloid, the presenilins and Alzheimer's diseaseTrends in Neurosciences, 1997
- Phosphorylation, Subcellular Localization, and Membrane Orientation of the Alzheimer's Disease-associated PresenilinsJournal of Biological Chemistry, 1997
- Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic miceNature Medicine, 1997
- Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In VivoNeuron, 1996
- Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1Nature, 1996
- Amyloid β-peptide is produced by cultured cells during normal metabolismNature, 1992